There were 1,660 press releases posted in the last 24 hours and 413,681 in the last 365 days.

Canna Care Docs Implores Maine Patients Seeking Medical Marijuana Treatment to Ensure Legal Procedures

North America’s Largest Multi-State Medical Cannabis Evaluation and Education Center Group Responds to Orono Police Raid

BANGOR, Maine, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Canna Care Docs, a CB2 Insights company and the largest and longest-running multi-state medical cannabis evaluation and education center group is calling on patients in Orono, Maine and the state at-large to seek out medical evaluations and educational support through channels that meet the regulations of the state.  This follows a large-scale police raid of an illegal operation offering prospective patients in Maine with an illegitimate process of integrating cannabis into their treatment plans.

Canna Care Docs notes that patients should be cautious of the following signs of unlawful cannabis businesses throughout the state:

  • Medical documentation and cards accepted by the state cannot be in electronic form – instead must be hard copies created by a certified healthcare provider;
  • Telemedicine appointments must be conducted within a HIPAA-compliant, secure portal and not in open forums such as Google Hangouts; and
  • Practitioners or clinics must not provide a promise of access to medicine prior to an evaluation.

“To-date, we have provided evaluations and care to over 250,000 patients and take our work within the healthcare industry very seriously,” said Stephanie Gluchacki, President of Clinical Operations, Canna Care Docs.  “Mainers deserve comprehensive and compliant care when they are seeking alternate treatment options for chronic pain, glaucoma, cancer-related symptoms, multiple sclerosis, seizures, or a host of other ailments.  At Canna Care Docs, we are committed to assessing the viability of cannabis as a treatment option and ensuring that patients receive the appropriate documentation and education according to the State’s regulations.”

Since 2014, Canna Care Docs has expanded to assist patients in Massachusetts, Maryland, Maine, Connecticut, Delaware, Rhode Island, Illinois and New York.  In Maine, Canna Care Docs has physical locations in Bangor, Biddeford and Winthrop and is also able to see patients through HIPAA-compliant telemedicine appointments throughout the state.

Please visit www.cannacaredocs.com for contact and address information.

About Canna Care Docs

Canna Care Docs is a caring and compassionate clinic group providing full-service assistance, education and physician evaluations for qualifying medical marijuana patients. CCD’s clinical operations cover eleven different states, with an extensive reach into Canada.  CCD offers compliant service adhering to the medical frameworks of the communities in which it operates, helping new and existing patients gain legal access to medical cannabis. Find cannabis-specific education and guidance, while connecting with a prescribing physician. Discover wellness and find healing with cannabis therapy and Canna Care Docs.  Canna Care Docs is a subsidiary of CB2 Insights.  For more information please visit www.cannacaredocs.com.

About CB2 Insights

CB2 Insights has a mission to simplify the medical cannabis journey across the value chain through a suite of healthcare technology products and services delivered through three distinct brands – each serving a unique vertical. Sail offers a comprehensive cannabis EMR platform and patient engagement tools to support clinics and clinicians across multiple countries. Canna Care Docs is a leading cannabis evaluation and education group operating in 12 jurisdictions. Canna Care Docs has served more than 265,000 patients looking to integrate cannabis into their treatment regimen. TokeIn is the industry’s only app-based customer loyalty and engagement platform used by cannabis retailers.  The parent brand, CB2 Insights, works to build predictive analytics tools based on the controlled data input ingested from each of its sub-brands which are used to deliver actionable insights both to its customer base and the industry at-large.   For more information please visit www.cb2insights.com, www.sailcannabis.co, www.cannacaredocs.com and www.tokein.com.

For more information, please contact:

Dan Thompson
Chief Marketing Officer
1.416.670.9316
dan.thompson@cb2insights.ca

CCD-logo.png